STERIS plc STE

208.93 0.16 0.08% as of 25 Sep
Market cap
$20.4B
P/E
25.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

STERIS plc (STE) Price to free cash flow

As of 25 September 2026, STERIS plc (STE) trades at a price to free cash flow of 21.8×. Over the past ten years it has ranged from 13.8× (June 2015) to 61.8× (April 2022); the current reading is higher than 12% of that period. That is in line with the Medical Devices industry median of 22.5× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2026 22.1× (22.18%)
FY2025 28.4× (19.35%)
FY2024 35.2× (24.41%)
FY2023 46.6× (21.21%)
FY2022 59.1× 64.22%
FY2021 36.0× 15.31%
FY2020 31.2× 2.91%
FY2019 30.3× 15.32%
FY2018 26.3× 13.42%
FY2017 23.2× (40.40%)

Quarterly

Period Price to free cash flow Change
Jun 2026 22.0× (0.62%)
Mar 2026 22.1× (16.88%)
Dec 2025 26.6× 5.93%
Sep 2025 25.1× (2.55%)
42 more quarters

Against its own ten years

Low 13.8× High 61.8×
Ten-year median 32.0×
Current reading's percentile 12

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 6.0×
PHG Koninklijke Philips N.V. compare 12.9×
ZBH Zimmer Biomet Holdings, Inc. compare 16.9×
GEHC GE HealthCare Technologies Inc. compare 19.1×
STE STERIS plc 21.8×
DXCM DexCom, Inc. compare 23.6×
BIO.B Bio-Rad Laboratories, Inc. compare 27.5×
BIO Bio-Rad Laboratories, Inc. compare 28.7×
PEN Penumbra, Inc. compare 58.1×
Medical Devices industry median 22.5×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on STE